Evidence map›Paper›PMID 42903533›Full record

ArticleQuantitative biology (Beijing, China)2026

miR2Meth: An R package for dissecting DNA methylation heterogeneity at microRNA promoters.

Ying Shan, Xiaoshan Rong, Andrew E Teschendorff, Zhen Yang

Abstract read
In one paragraph

Article in Quantitative biology (Beijing, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ying ShanDepartment of Obstetrics and Gynecology Shanghai Pudong Hospital Fudan University Pudong Medical Center Shanghai China.
Xiaoshan RongYangzhi Rehabilitation Hospital School of Medicine Tongji University Shanghai China.
Andrew E TeschendorffCAS Key Laboratory of Computational Biology Shanghai Institute of Nutrition and Health University of Chinese Academy of Sciences Chinese Academy of Sciences Shanghai China.
Zhen YangCenter for Medical Research and Innovation of Pudong Hospital, and Intelligent Medicine Institute Shanghai Medical College Fudan University Shanghai China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant expression of microRNAs (miRNAs) has been found in prevalent cancer types, yet the underlying mechanisms remain largely unexplored due to a lack of analytical tools. Studies have shown that DNA methylation (DNAm) plays a significant role in regulating miRNA expression. Here, we present miR2Meth, an R package to construct DNAm profiles for miRNAs by mapping the probes from the Illumina methylation BeadArray platforms to miRNA promoters. By integrating miRNA expression data, researchers are able to identify aberrant miRNAs associated with promoter methylation dysregulation. This software provides an easy-to-use tool to investigate the relationships between miRNAs and DNAm in human diseases. miR2Meth is freely available at GitHub website (github.com/zyangx/miR2Meth).

Indexed as

DNA methylationheterogeneitymicroRNAmulti‐omicspromoter

Identifiers

PMID42903533
PMCPMC13681029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.